Literature DB >> 15743818

BAF57 governs androgen receptor action and androgen-dependent proliferation through SWI/SNF.

Kevin A Link1, Craig J Burd, Erin Williams, Thomas Marshall, Gary Rosson, Erin Henry, Bernard Weissman, Karen E Knudsen.   

Abstract

Androgen receptor (AR) activity is required for prostate cancer development and progression. Thus, there is a major impetus to understand the regulation of AR action. We and others have previously shown that AR transactivation potential is dependent on the presence of an active SWI/SNF chromatin remodeling complex. However, the mechanisms underlying SWI/SNF regulation of the AR remained unsolved. We show here that the BAF57 subunit, an accessory component of the remodeling complex, is a critical regulator of AR function. We show that BAF57 is expressed in the luminal epithelia of the prostate and is required for AR-dependent transactivation in prostatic adenocarcinoma cells. Our data reveal that BAF57 can directly bind to the AR and is recruited to endogenous AR targets upon ligand activation. Loss of BAF57 or inhibition of BAF57 function severely compromised AR activity, as observed with both exogenous and endogenous AR targets. Rescue of BAF57 function restored AR activity, thus demonstrating a specific requirement of BAF57 for AR activity. This action of BAF57 proved to be dependent on SWI/SNF ATPase function. BAF57 has previously been implicated in nuclear receptor coactivator function, and we show that, although BAF57 facilitated coactivator activity, only a selected subset required BAF57 for coactivator function. Lastly, we demonstrate that both BAF57 and BRM are required for the proliferation of AR-dependent prostatic adenocarcinoma cells. In summary, these findings identify BAF57 as a critical modulator of the AR that is capable of altering AR activity, coactivator function, and AR-dependent proliferation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15743818      PMCID: PMC1061596          DOI: 10.1128/MCB.25.6.2200-2215.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  76 in total

1.  Ubc9 interacts with the androgen receptor and activates receptor-dependent transcription.

Authors:  H Poukka; P Aarnisalo; U Karvonen; J J Palvimo; O A Jänne
Journal:  J Biol Chem       Date:  1999-07-02       Impact factor: 5.157

Review 2.  Mechanisms of androgen receptor activation and function.

Authors:  A O Brinkmann; L J Blok; P E de Ruiter; P Doesburg; K Steketee; C A Berrevoets; J Trapman
Journal:  J Steroid Biochem Mol Biol       Date:  1999 Apr-Jun       Impact factor: 4.292

3.  Active transcriptional repression by the Rb-E2F complex mediates G1 arrest triggered by p16INK4a, TGFbeta, and contact inhibition.

Authors:  H S Zhang; A A Postigo; D C Dean
Journal:  Cell       Date:  1999-04-02       Impact factor: 41.582

Review 4.  Roles of histone acetyltransferases and deacetylases in gene regulation.

Authors:  M H Kuo; C D Allis
Journal:  Bioessays       Date:  1998-08       Impact factor: 4.345

Review 5.  Co-activators and co-repressors in the integration of transcriptional responses.

Authors:  J Torchia; C Glass; M G Rosenfeld
Journal:  Curr Opin Cell Biol       Date:  1998-06       Impact factor: 8.382

6.  Cloning and characterization of androgen receptor coactivator, ARA55, in human prostate.

Authors:  N Fujimoto; S Yeh; H Y Kang; S Inui; H C Chang; A Mizokami; C Chang
Journal:  J Biol Chem       Date:  1999-03-19       Impact factor: 5.157

Review 7.  The role of the androgen receptor in the development and progression of prostate cancer.

Authors:  G Jenster
Journal:  Semin Oncol       Date:  1999-08       Impact factor: 4.929

8.  Altered control of cellular proliferation in the absence of mammalian brahma (SNF2alpha).

Authors:  J C Reyes; J Barra; C Muchardt; A Camus; C Babinet; M Yaniv
Journal:  EMBO J       Date:  1998-12-01       Impact factor: 11.598

9.  Multiple G1 regulatory elements control the androgen-dependent proliferation of prostatic carcinoma cells.

Authors:  K E Knudsen; K C Arden; W K Cavenee
Journal:  J Biol Chem       Date:  1998-08-07       Impact factor: 5.157

10.  Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer.

Authors:  I Versteege; N Sévenet; J Lange; M F Rousseau-Merck; P Ambros; R Handgretinger; A Aurias; O Delattre
Journal:  Nature       Date:  1998-07-09       Impact factor: 49.962

View more
  55 in total

Review 1.  General molecular biology and architecture of nuclear receptors.

Authors:  Michal Pawlak; Philippe Lefebvre; Bart Staels
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

2.  The human SWI/SNF complex associates with RUNX1 to control transcription of hematopoietic target genes.

Authors:  Rachit Bakshi; Mohammad Q Hassan; Jitesh Pratap; Jane B Lian; Martin A Montecino; Andre J van Wijnen; Janet L Stein; Anthony N Imbalzano; Gary S Stein
Journal:  J Cell Physiol       Date:  2010-11       Impact factor: 6.384

3.  Regulating SWI/SNF subunit levels via protein-protein interactions and proteasomal degradation: BAF155 and BAF170 limit expression of BAF57.

Authors:  Jianguang Chen; Trevor K Archer
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

4.  Deleted in breast cancer 1, a novel androgen receptor (AR) coactivator that promotes AR DNA-binding activity.

Authors:  Junjiang Fu; Jun Jiang; Jiwen Li; Shanshan Wang; Guang Shi; Qin Feng; Eileen White; Jun Qin; Jiemin Wong
Journal:  J Biol Chem       Date:  2009-01-05       Impact factor: 5.157

Review 5.  Minireview: Conversing with chromatin: the language of nuclear receptors.

Authors:  Simon C Biddie; Sam John
Journal:  Mol Endocrinol       Date:  2013-01-01

Review 6.  Hijacking the chromatin remodeling machinery: impact of SWI/SNF perturbations in cancer.

Authors:  Bernard Weissman; Karen E Knudsen
Journal:  Cancer Res       Date:  2009-10-20       Impact factor: 12.701

Review 7.  Rationale for the development of alternative forms of androgen deprivation therapy.

Authors:  Sangeeta Kumari; Dhirodatta Senapati; Hannelore V Heemers
Journal:  Endocr Relat Cancer       Date:  2017-05-31       Impact factor: 5.678

8.  Aberrant BAF57 signaling facilitates prometastatic phenotypes.

Authors:  Sucharitha Balasubramaniam; Clay E S Comstock; Adam Ertel; Kwang Won Jeong; Michael R Stallcup; Sankar Addya; Peter A McCue; William F Ostrander; Michael A Augello; Karen E Knudsen
Journal:  Clin Cancer Res       Date:  2013-03-14       Impact factor: 12.531

9.  The BAF chromatin remodelling complex is an epigenetic regulator of lineage specification in the early mouse embryo.

Authors:  Maryna Panamarova; Andy Cox; Krzysztof B Wicher; Richard Butler; Natalia Bulgakova; Shin Jeon; Barry Rosen; Rho H Seong; William Skarnes; Gerald Crabtree; Magdalena Zernicka-Goetz
Journal:  Development       Date:  2016-03-07       Impact factor: 6.868

10.  Heterogeneous SWI/SNF chromatin remodeling complexes promote expression of microphthalmia-associated transcription factor target genes in melanoma.

Authors:  B Keenen; H Qi; S V Saladi; M Yeung; I L de la Serna
Journal:  Oncogene       Date:  2009-09-28       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.